Bare metal stents plus oral rapamycin are more cost effective than drug eluting stents in patients undergoing PCI for de novo coronary lesions: Insights from the randomized,controlled ORAR III study

被引：0
|
作者：
Fernandez-Pereira, Carlos
Mieres, Juan
Risau, Gustavo
Santaera, Omar
Rodriguez-Granillo, Alfredo M.
Rodriguez-Granillo, Gaston A.
Mauree, Andrew O.
Palacios, Igor F.
Rodriquez, Alfredo E.
机构：
[1] Santario Otamendi, Buenos Aires, DF, Argentina
[2] Massachusetts Gen Hosp, Boston, MA USA
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2008年 / 51卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：B88 / B88
页数：1
相关论文
共 50 条
  • [31] Neointimal response to second-generation drug-eluting stents in diabetic patients with de-novo coronary lesions: intravascular ultrasound study
    Won, Hoyoun
    Kang, Tae Soo
    Hong, Bum-Kee
    Lee, Seunghwan
    Jeon, Dong Woon
    Ryu, Sung Kee
    Min, Pil-Ki
    Yoon, Young Won
    Lee, Byoung Kwon
    Kwon, Hyuck Moon
    Ko, Young-Guk
    Jang, Yangsoo
    CORONARY ARTERY DISEASE, 2015, 26 (03) : 212 - 219
  • [32] DRUG-ELUTING VERSUS BARE-METAL STENTS IN TREATMENT OF DIABETIC PATIENTS WITH ACUTE CORONARY SYNDROMES: ANALYSIS FROM THE RANDOMIZED ACUITY TRIAL
    Challa, Karthik K.
    Nikolsky, Eugenia
    Mehran, Roxana
    Lansky, Alexandra J.
    Dangas, George D.
    Caixeta, Adriano
    McLaurin, Brent T.
    Cox, David A.
    Moses, Jeffrey W.
    Feit, Frederick
    Embacher, Monica
    Stone, Gregg W.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2010, 55 (10)
  • [33] Intravascular ultrasound analysis of ABT-578 eluting phosphorylcholine-coated cobalt-chromium stents compared to bare metal stents in de novo coronary lesions: Results from the ENDEAVOR II trial
    Sakurai, R
    Hongo, Y
    Honda, Y
    Cutlip, D
    Popma, JJ
    Zimetbaum, P
    Yock, PG
    Fajadet, J
    Kuntz, RE
    Wijns, W
    Fitzgerald, PJ
    AMERICAN JOURNAL OF CARDIOLOGY, 2005, 96 (7A): : 184H - 184H
  • [34] Erratum to: Comparison of a drug-eluting balloon first and then bare metal stent with a drug-eluting stent for treatment of de novo lesions: study protocol of a randomized controlled trial
    Sang-Don Park
    Chang-Hwan Yoon
    Il-Young Oh
    Jung-Won Suh
    Young-Suk Cho
    Tae-Jin Youn
    Dong-Ju Choi
    In-Ho Chae
    Trials, 18
  • [35] Incidence and Predictors of Target Lesion Failure in PatientsWith Lesions in Small Vessels Undergoing PCI With Contemporary Drug-Eluting Stents: Insights From the BIONICS Study
    Danenberg, Haim D.
    Konigstein, Maayan
    Golomb, Mordechai
    Kandzari, David E.
    Smits, Pieter C.
    Love, Michael P.
    Banai, Shmuel
    Ozan, Melek Ozgu
    Liu, Mengdan
    Perlman, Gidon Y.
    Stone, Gregg W.
    Ben-Yehuda, Ori
    CARDIOVASCULAR REVASCULARIZATION MEDICINE, 2021, 25 : 1 - 8
  • [36] Does Current Evidence Favor Drug-Eluting Stents Over Bare-Metal Stents for Saphenous Venous Graft Interventions? Insights From an Updated Meta-Analysis of Randomized Controlled Trials
    Bavishi, Chirag
    Chatterjee, Saurav
    Stone, Gregg W.
    JACC-CARDIOVASCULAR INTERVENTIONS, 2016, 9 (23) : 2456 - 2458
  • [37] Long-Term Clinical Benefit of Drug-Eluting Stents Over Bare-Metal Stents in Diabetic Patients With De Novo Left Main Coronary Artery Disease: Results From a Real-World Multicenter Registry
    Capodanno, Davide
    Di Salvo, Maria Elena
    Palmerini, Tullio
    Sheiban, Imad
    Margheri, Massimo
    Vecchi, Giuseppe
    Sangiorgi, Giuseppe
    Piovaccari, Giancarlo
    Bartorelli, Antonio
    Briguori, Carlo
    Ardissino, Diego
    Di Pede, Francesco
    Ramondo, Angelo
    Inglese, Luigi
    Petronio, Anna Sonia
    Bolognese, Leonardo
    Benassi, Alberto
    Palmieri, Cataldo
    Filippone, Vincenzo
    De Servi, Stefano
    Tamburino, Corrado
    CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2009, 73 (03) : 310 - 316
  • [38] Results in long term outcome of patients with multiple vessel disease treated with drug eluting,bare metal stents and coronary bypass surgery: insights from five years follow up of ERACI III study
    Rodriguez, A.
    Hlatky, M.
    Grinfeld, L.
    Mieres, J.
    Rodriguez-Granillo, M. A.
    Berrocal, D.
    Boothroyd, D.
    Fernandez-Pereira, C.
    Palacios, I. P.
    Oneill, W.
    EUROPEAN HEART JOURNAL, 2010, 31 : 219 - 219
  • [39] Long Term Cardiovascular Outcomes with Drug-Eluting Stents vs. Bare-Metal Stents in Saphenous Vein Graft Interventions: Insights from an Updated Meta-Analysis of Randomized Controlled Trials
    Kundu, Amartya
    Sardar, Partha
    Chatterjee, Saurav
    Bavishi, Chirag
    Kakouros, Nikolaos
    Aronow, Herbert
    Rade, Jeffrey
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2018, 72 (13) : B209 - B210
  • [40] Improved Late Clinical Safety With Zotarolimus-Eluting Stents Compared With Paclitaxel-Eluting Stents in Patients With De Novo Coronary Lesions 3-Year Follow-Up From the ENDEAVOR IV (Randomized Comparison of Zotarolimus- and Paclitaxel-Eluting Stents in Patients With Coronary Artery Disease) Trial
    Leon, Martin B.
    Nikolsky, Eugenia
    Cutlip, Donald E.
    Mauri, Laura
    Liberman, Henry
    Wilson, Hadley
    Patterson, John
    Moses, Jeffrey
    Kandzari, David E.
    JACC-CARDIOVASCULAR INTERVENTIONS, 2010, 3 (10) : 1043 - 1050
12345